• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Tired-eye supplement introduced at the American Optometric Association

Article

At the recent American Optometric Association annual congress, Astavita Professional introduced astaxanthin (AstaREAL, Fuji Health Science) for the relief and prevention of asthenopia.

Key Points

Burlington, NJ-At the recent American Optometric Association annual congress, Astavita Professional introduced astaxanthin (AstaREAL, Fuji Health Science) for the relief and prevention of asthenopia.

Asthenopia is characterized by sensitivity to glare, headaches, sore eyes, and blurred vision. Fuji Chemical Industry of Japan's 11 human clinical studies of an all-natural antioxidant-astaxanthin-have shown significant positive results against asthenopia.

Astaxanthin acts as both a lipid-soluble and water-soluble antioxidant to reduce cellular inflammation while protecting cells. Supporting studies have shown that astaxanthin increases capillary blood flow and improves ciliary body function, as well as increases the endurance and recovery of muscles after overuse, exercise, and other forms of stress.

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.